Nov. 13, 2025 — Nano-X Imaging Ltd., a medical imaging technology company, will showcase its Nanox.ARC X multi-source digital tomosynthesis system and highlight development of new solutions for its AI portfolio at the Radiological Society of North America (RSNA) 2025 Annual Meeting, Nov. 30 - Dec. 4, 2025 in Chicago, IL.
The Nanox.ARC X, an AI-ready, multi-source digital tomosynthesis system that makes advanced 3D imaging possible in more places at significantly lower cost and radiation dose than CT, received FDA 510(k) clearance in April 2025 for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications. At RSNA 2025, attendees will have their first opportunity to see live demonstrations of the system. Nanox will showcase its full end-to-end imaging solution, which includes the Nanox.ARC X and its suite of FDA-cleared, AI-powered software that analyzes routine CT scans to identify early signs of chronic conditions.
Live demonstrations of the Nanox.ARC X will be featured at Booth #3914 (South Hall Level 3) every 30 minutes, and the Company will present clinical data supporting digital tomosynthesis across multiple applications. Nanox will also announce a pulmonary nodule AI solution currently under development as a future component of the Nanox.ARC X, as well as two new standalone AI innovations for aortic valve calcification measurement and body composition measurements.
“We are excited to unveil the Nanox.ARC X system to the radiology community for the first time. The system bridges the gap between conventional X-rays and CT scans, bringing advanced 3D imaging to everyday care settings where it hasn’t been practical before,” said Erez Meltzer, CEO and Acting Chairman of Nanox. “We will also be highlighting our expanding AI portfolio, featuring two new AI innovations in development. We’re delivering on our vision to leverage our AI and proprietary digital X-ray source technology to make advanced medical imaging accessible to more patients, in more places.”
More details about Nanox’s RSNA 2025 presentations and events are as follows.
RSNA Innovation Theater Presentation: Nanox: From Vision to Reality – AI and Digital Tomosynthesis in Pulmonary Nodule Detection
- Presenter: Orit Wimpfheimer, MD (Chief Medical Officer of Nanox)
- Location: Innovation Theater, Booth 3316, South Hall A
- Day/Time: Dec. 2, 11 am CT
Educational Exhibit Poster Presentation: Applications of Digital Tomosynthesis in the Musculoskeletal System
- Authors: Nogah Shabshin, MD, Mor Armoni, Yotam Kimmel, Guy Yoskovitz, Yael S. Schiffenbauer, PhD, Ophir Robenpour, MD, Sigal Tal, MD, Yiftah Beer, MD
- Location: Learning Center, East Level 3
- Session Title: MKEE. Musculoskeletal Imaging Education Exhibits
- Session Start: Nov. 30, 7:30 am CT
Cocktail Event (Please contact Nanox team to register)
- Host: Lawrence Tanenbaum, MD (Nanox Advisory Board Member)
- Location: VU Rooftop Bar, 22nd floor of Hilton Garden Inn, McCormick Place
- Day/Time: December 1, 5:30 pm CT
Nanox representatives will be available throughout RSNA 2025 for product demonstrations, clinical discussions, and partnership opportunities. Schedule a meeting at the following links:
March 13, 2026 
